Treatment Advances in Prostate Cancer

 

PrecisCa
Avatar

Treatment Approach for Patients With mCSPC

By PrecisCa FEATURING Matthew Rettig
By PrecisCa FEATURING Matthew Rettig
175 views
December 28, 2022
0 Comments
Login to view comments. Click here to Login
Treatment Advances in Prostate Cancer
17:11
ecancer

ASCO® 2023 Summary: "Latest in PARPi in Prostate Cancer - PROpe…

Feat. R. McKay, F. Schlürmann, G. von Amsberg
02:32
Dana-Farber Cancer Institute

ASCO® 2023 Insights: "Prognostic Impact of PSA Nadir (n)≥0.1ng/…

Feat. P. Ravi
08:59
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Poster Sessions From Dr. Andrew Armstrong in Prostate Can…

Feat. A. Armstrong
05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
25:33
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Feat. J. Berchuck, A. Choudhury
15:51
Judd Moul

A Multidisciplinary Team Approach to Prostate Cancer

06:49
ASCO GU 2023 Conference Coverage

ASCO GU 2023 DEAR Study: Real-World Use of Darolutamide, Enzalutamid…

Feat. D. George
21:19
2023 West Oncology Conference

2023 West Oncology Conference: Latest Updates in Advanced Prostate C…

Feat. B. Somer
22:10
ecancer

ASCO GU 2023 Latest in HSPC

Feat. E. Efstathiou, B. Hadaschik, G. Attard, H. Payne
12:39
ASCO GU 2023 Conference Coverage

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

Feat. C. Sternberg
25:38
OncoAlert

Advances in the Treatment Landscape of Metastatic Prostate Cancer

Feat. N. Agarwal
14:01
ASCO GU 2023 Conference Coverage

ASCO GU 2023 Active Surveillance for Favorable Intermediate-Risk Pro…

Feat. A. D'Amico
05:41
Fred Saad

ARASENS Trial Updates: OS With Darolutamide vs. Placebo in Combinati…

11:12
E. David Crawford

Phase 3 ARASENS Trial: Overall Safety & Incidences of Adverse Ev…

34:51
Houston Methodist Hospital

In Pursuit of Precision Medicine for Prostate Cancer Patients: Recen…

Feat. E. Efstathiou
20:52
PROSCA & BLADDR 2022

AR Antagonists for Prostate Cancer: Are They All Equal?

Feat. B. Tombal
07:50
PrecisCa

Treatment Approach for Patients With mCSPC

Feat. M. Rettig
05:32
PrecisCa

When to Use Genomic Testing for Prostate Cancer

Feat. P. Patel
09:09
Robert Dreicer

Evolving Management of Castration-Sensitive Metastatic Prostate Canc…